KESON-BROOKES MAIKEN (CLO & Corp. Secretary) sold 25K shares of RUBIUS THERAPEUTICS, INC. on the open market
Open‑market sale worth $506.0K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/15/2021ACC: 0001179110-21-003441
Officer· CLO & Corp. Secretary
Since Nov 2019
-25K
Net shares
Net seller
$506.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
25K acquired · 50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25K
Price / share
$7.70
Trade value
$192.50K
% of position
New position
3/15/2021
0.00→25K
Common Stock
Direct
Shares
−25K
Price / share
$20.24
Trade value
$505.97K
% of position
New position
3/15/2021
25K→0.00
Total
Net shares
+0.00
Net value
-$313.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2021 | M · Option Exercise | +25K | $7.70 | $192.50K | New position | 0.00 | 25K |
| Common Stock Direct | 3/15/2021 | S · Sale | −25K | $20.24 | $505.97K | New position | 25K | 0.00 |
| Total | +0.00 | -$313.47K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
25K shares
Shares
−25K
Strike price
7.70
Held after
225K
Exercisable
—
3/15/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock25K shares | 3/15/2021 | M · Option Exercise | −25K | 7.70 | — | 225K |